{
  "index": {
    "countriesScore": {
      "Australia": 90,
      "Austria": 90,
      "Belgium": 80,
      "Canada": 90,
      "China": 20,
      "Cuba": 10,
      "Denmark": 90,
      "Finland": 90,
      "France": 80,
      "Germany": 80,
      "Hong Kong": 90,
      "Hungary": 60,
      "Iceland": 90,
      "India": 50,
      "Ireland": 90,
      "Israel": 70,
      "Italy": 50,
      "Japan": 80,
      "Lithuania": 60,
      "Malaysia": 50,
      "Netherlands": 90,
      "New Zealand": 95,
      "Norway": 90,
      "Portugal": 70,
      "Russia": 25,
      "South Korea": 70,
      "Spain": 70,
      "Sweden": 90,
      "Switzerland": 90,
      "Taiwan": 70,
      "UK": 85,
      "USA": 85,
      "Others": 50
    },
    "countries": [
      "Australia",
      "Austria",
      "Belgium",
      "Canada",
      "China",
      "Cuba",
      "Denmark",
      "Finland",
      "France",
      "Germany",
      "Hong Kong",
      "Hungary",
      "Iceland",
      "India",
      "Ireland",
      "Israel",
      "Italy",
      "Japan",
      "Lithuania",
      "Malaysia",
      "Netherlands",
      "New Zealand",
      "Norway",
      "Portugal",
      "Russia",
      "South Korea",
      "Spain",
      "Sweden",
      "Switzerland",
      "Taiwan",
      "UK",
      "USA",
      "Others"
    ],
    "npdCycleStages": [
      "Formulation",
      "Discovery",
      "Lead Molecule",
      "Preclinical",
      "Phase I",
      "Phase II",
      "Phase III",
      "BLA/NDA Filed",
      "Approved/Marketing"
    ]
  }
}